Clinical trial
An Observational Proof-of-concept Study to Explore the Waveform Characteristics of Tidal Breathing Carbon Dioxide (CO2), Measured Using the N-Tidal C™ Device, in Different Breathing Conditions.
NCT03356288 is registered in ClinicalTrials.gov with TidalSense as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Proof-of-concept Study to Explore the Waveform Characteristics of Tidal Breathing Carbon Dioxide (CO2), Measured Using the N-Tidal C™ Device, in Different Breathing Conditions.
- Lead sponsor
- TidalSense
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 9, 2017
- Completion date
- July 4, 2018
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asthma, breathlessness, heart failure, motor neuron disease, pneumonia, vocal cord dysfunction